Pharma Litigation Threatens to Limit State Drug Pricing Policy

The generic drug industry aims to build on its success in challenging state anti-price gouging laws with a new lawsuit filed in Illinois—the outcome of which analysts say will affect policy makers’ willingness to pursue efforts to rein in drug costs.

The complaint filed Jan. 22 by the Association for Accessible Medicines, which represents generic and biosimilar manufacturers, alleges an Illinois law (HB 3957) imposing penalties for certain generic drug price increases improperly seeks to regulate commerce outside the state. The group wants the US District Court for the Northern District of Illinois to enjoin state officials from ...